SCHEMBL7174243

SCHEMBL7174243

O=CCOC(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.52
ALOX12 P18054 1/20 0.52
TSHR P16473 2/20 0.50
ATM Q13315 1/20 0.50
CYP3A4 P08684 1/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
RECQL P46063 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
P2RX7 Q99572 1/20 0.41
JAK2 O60674 2/20 0.39
NPC1 O15118 2/20 0.39
MEN1 O00255 1/20 0.39
S1PR2 O95136 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5663870 0.86 CYP3A4 (0.53) L3MBTL1TSHRCYP3A4ALDH1A1HSD17B10
SCHEMBL27794808 0.81 L3MBTL1 (0.56) L3MBTL1ALOX12TSHRATMERCC5
SCHEMBL3316733 0.81 L3MBTL1 (0.46) L3MBTL1FEN1ALDH1A1MEN1LMNA
SCHEMBL11418791 0.79 TSHR (0.63) L3MBTL1ALOX12TSHRATMCYP3A4
SCHEMBL5666596 0.77 L3MBTL1 (0.44) L3MBTL1CYP3A4ALDH1A1NPC1LMNA
SCHEMBL27312748 0.77 ALDH1A1 (0.66) L3MBTL1ALOX12TSHRATMCYP3A4
SCHEMBL29566931 0.76 TSHR (0.63) L3MBTL1ALOX12TSHRATMERCC5
SCHEMBL36590 0.76 TSHR (0.63) L3MBTL1ALOX12TSHRATMERCC5
SCHEMBL5955449 0.76 TSHR (0.63) L3MBTL1ALOX12TSHRATMERCC5
SCHEMBL5666270 0.76 CYP3A4 (0.53) L3MBTL1TSHRCYP3A4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576614-B1 Administering methyl ketones or closed hemiketal derivatives of aspartic acid VERTEX PHARMACEUTICALS INCORPORATED 2003-06-10 US disclosed
US-5985838-A TREATING INFECTIOUS DISEASE, RESPIRATORY DISEASE, INFLAMMATORY CONDITIONS, IMMUNE-BASED DISEASE, AUTO-IMMUNE DISEASE, BONE DISEASE, AND TUMORS VERTEX PHARMACEUTICALS, INC. (US) 1999-11-16 US disclosed